Product Code: 137049-05-23
Paper Diagnostics Market is Expected to Grow at 7.5% by 2031. Paper diagnostics are devices made of paper and cellulosic materials to recognize and quantify biomolecules and chemicals affecting health. There has been a rapid increase in interest for paper-based diagnostic methods in recent years. This is because paper is cheap, widely available, easily engineered, biodegradable, combustible, biocompatible, sterilizable, hydrophilic, and easy to functionalize and process into diagnostic devices. Paper diagnostic work on principle of a chemical reaction between the coating on the paper and substance that is to be tested, which produces a visible result that can be used for diagnosis. Due to the clear guidelines regarding the meaning of each visible result, paper diagnostics can even be used by untrained patients. This has resulted in a sturdy demand for paper diagnostics from patients suffering from conditions that require regular self-diagnosis.
Increasing prevalence of infectious diseases and lifestyle-related diseases has resulted in the growth of point-of-care diagnostics. In addition, rise in the geriatric population globally have also led to growth opportunities for the paper diagnostics market. Rising acceptance of cost-effective and easily available rapid POC diagnostics especially in the developing economies of Asia Pacific region is expected to boost the market growth of paper diagnostics over the forecast period. The introduction of paper-based sensors, 3D wax printing devices which are technologically advanced, and have exhibit potential advantages over conventional diagnostic technologies, such as user-friendliness, disposable nature, and low cost of production are the factors attributing to the growth of this market.
Key Players Identified for Paper Diagnostic Market Include:
ARKRAY Inc., Acon Laboratories, Inc., Abbott, Bio-Rad Laboratories, Abcam Plc, Chembio Diagnostic Systems, Inc., FFEI, Navigene, Creative Diagnostics, and Siemens Healthcare Gmbh
Historical & Forecast Period
This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Paper Diagnostics market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Paper Diagnostics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Segmentation
Product
- Lateral Flow Assays
- Dipsticks
- Paper-Based Microfluidics
Device
- Diagnostic Devices
- Monitoring Devices
End-User
- Assisted Living Healthcare Facilities
- Home Healthcare
- Hospital and Clinics
Application
- Clinical Diagnostics
- Cancer
- Infectious diseases
- Other
- Food Quality Testing
- Environmental Monitoring
Region Segment (2021-2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report:
- What are the key micro and macro environmental factors that are impacting the growth of Paper Diagnostics market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Paper Diagnostics market?
- Which is the largest regional market for Paper Diagnostics market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Paper Diagnostics market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Paper Diagnostics market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Paper Diagnostics Market
- 2.2. Global Paper Diagnostics Market, By Product, 2022 (US$ Million)
- 2.3. Global Paper Diagnostics Market, By Device, 2022 (US$ Million)
- 2.4. Global Paper Diagnostics Market, By End-User, 2022 (US$ Million)
- 2.5. Global Paper Diagnostics Market, By Application, 2022 (US$ Million)
- 2.6. Global Paper Diagnostics Market, By Geography, 2022 (US$ Million)
- 2.7. Attractive Investment Proposition by Geography, 2022
3. Paper Diagnostics Market: Competitive Analysis
- 3.1. Market Positioning of Key Paper Diagnostics Market Vendors
- 3.2. Strategies Adopted by Paper Diagnostics Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Paper Diagnostics Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Paper Diagnostics Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Lateral Flow Assays
- 5.3.2. Dipsticks
- 5.3.3. Paper-Based Microfluidics
6. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Diagnostic Devices
- 6.3.2. Monitoring Devices
7. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2022 Versus 2031
- 7.3. Market Segmentation
- 7.3.1. Assisted Living Healthcare Facilities
- 7.3.2. Home Healthcare
- 7.3.3. Hospital and Clinics
8. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Growth & Revenue Analysis: 2022 Versus 2031
- 8.3. Market Segmentation
- 8.3.1. Clinical Diagnostics
- 8.3.2. Cancer
- 8.3.3. Infectious diseases
- 8.3.4. Other
- 8.3.5. Food Quality Testing
- 8.3.6. Environmental Monitoring
9. North America Paper Diagnostics Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 9.3. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 9.4. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 9.5. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 9.6.Paper Diagnostics Market: By Region, 2021-2031, USD (Million)
- 9.6.1.North America
- 9.6.1.1. U.S.
- 9.6.1.1.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 9.6.1.1.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 9.6.1.1.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 9.6.1.1.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 9.6.1.2. Canada
- 9.6.1.2.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 9.6.1.2.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 9.6.1.2.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 9.6.1.2.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 9.6.1.3. Rest of North America
- 9.6.1.3.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 9.6.1.3.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 9.6.1.3.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 9.6.1.3.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
10. UK and European Union Paper Diagnostics Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 10.3. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 10.4. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 10.5. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 10.6.Paper Diagnostics Market: By Region, 2021-2031, USD (Million)
- 10.6.1.UK and European Union
- 10.6.1.1. UK
- 10.6.1.1.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 10.6.1.1.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 10.6.1.1.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 10.6.1.1.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 10.6.1.2. Germany
- 10.6.1.2.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 10.6.1.2.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 10.6.1.2.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 10.6.1.2.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 10.6.1.3. Spain
- 10.6.1.3.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 10.6.1.3.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 10.6.1.3.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 10.6.1.3.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 10.6.1.4. Italy
- 10.6.1.4.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 10.6.1.4.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 10.6.1.4.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 10.6.1.4.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 10.6.1.5. France
- 10.6.1.5.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 10.6.1.5.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 10.6.1.5.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 10.6.1.5.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 10.6.1.6. Rest of Europe
- 10.6.1.6.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 10.6.1.6.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 10.6.1.6.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 10.6.1.6.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
11. Asia Pacific Paper Diagnostics Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 11.3. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 11.4. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 11.5. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 11.6.Paper Diagnostics Market: By Region, 2021-2031, USD (Million)
- 11.6.1.Asia Pacific
- 11.6.1.1. China
- 11.6.1.1.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 11.6.1.1.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 11.6.1.1.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 11.6.1.1.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 11.6.1.2. Japan
- 11.6.1.2.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 11.6.1.2.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 11.6.1.2.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 11.6.1.2.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 11.6.1.3. India
- 11.6.1.3.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 11.6.1.3.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 11.6.1.3.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 11.6.1.3.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 11.6.1.4. Australia
- 11.6.1.4.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 11.6.1.4.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 11.6.1.4.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 11.6.1.4.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 11.6.1.5. South Korea
- 11.6.1.5.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 11.6.1.5.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 11.6.1.5.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 11.6.1.5.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 11.6.1.6. Rest of Asia Pacific
- 11.6.1.6.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 11.6.1.6.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 11.6.1.6.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 11.6.1.6.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
12. Latin America Paper Diagnostics Market, 2021-2031, USD (Million)
- 12.1. Market Overview
- 12.2. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 12.3. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 12.4. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 12.5. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 12.6.Paper Diagnostics Market: By Region, 2021-2031, USD (Million)
- 12.6.1.Latin America
- 12.6.1.1. Brazil
- 12.6.1.1.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 12.6.1.1.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 12.6.1.1.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 12.6.1.1.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 12.6.1.2. Mexico
- 12.6.1.2.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 12.6.1.2.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 12.6.1.2.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 12.6.1.2.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 12.6.1.3. Rest of Latin America
- 12.6.1.3.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 12.6.1.3.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 12.6.1.3.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 12.6.1.3.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
13. Middle East and Africa Paper Diagnostics Market, 2021-2031, USD (Million)
- 13.1. Market Overview
- 13.2. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 13.3. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 13.4. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 13.5. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 13.6.Paper Diagnostics Market: By Region, 2021-2031, USD (Million)
- 13.6.1.Middle East and Africa
- 13.6.1.1. GCC
- 13.6.1.1.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 13.6.1.1.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 13.6.1.1.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 13.6.1.1.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 13.6.1.2. Africa
- 13.6.1.2.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 13.6.1.2.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 13.6.1.2.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 13.6.1.2.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
- 13.6.1.3. Rest of Middle East and Africa
- 13.6.1.3.1. Paper Diagnostics Market: By Product, 2021-2031, USD (Million)
- 13.6.1.3.1. Paper Diagnostics Market: By Device, 2021-2031, USD (Million)
- 13.6.1.3.1. Paper Diagnostics Market: By End-User, 2021-2031, USD (Million)
- 13.6.1.3.1. Paper Diagnostics Market: By Application, 2021-2031, USD (Million)
14. Company Profile
- 14.1. ARKRAY Inc.
- 14.1.1. Company Overview
- 14.1.2. Financial Performance
- 14.1.3. Product Portfolio
- 14.1.4. Strategic Initiatives
- 14.2. Acon Laboratories, Inc.
- 14.2.1. Company Overview
- 14.2.2. Financial Performance
- 14.2.3. Product Portfolio
- 14.2.4. Strategic Initiatives
- 14.3. Abbott
- 14.3.1. Company Overview
- 14.3.2. Financial Performance
- 14.3.3. Product Portfolio
- 14.3.4. Strategic Initiatives
- 14.4. Bio-Rad Laboratories
- 14.4.1. Company Overview
- 14.4.2. Financial Performance
- 14.4.3. Product Portfolio
- 14.4.4. Strategic Initiatives
- 14.5. Abcam Plc
- 14.5.1. Company Overview
- 14.5.2. Financial Performance
- 14.5.3. Product Portfolio
- 14.5.4. Strategic Initiatives
- 14.6. Chembio Diagnostic Systems, Inc.
- 14.6.1. Company Overview
- 14.6.2. Financial Performance
- 14.6.3. Product Portfolio
- 14.6.4. Strategic Initiatives
- 14.7. FFEI
- 14.7.1. Company Overview
- 14.7.2. Financial Performance
- 14.7.3. Product Portfolio
- 14.7.4. Strategic Initiatives
- 14.8. Navigene
- 14.8.1. Company Overview
- 14.8.2. Financial Performance
- 14.8.3. Product Portfolio
- 14.8.4. Strategic Initiatives
- 14.9. Creative Diagnostics
- 14.9.1. Company Overview
- 14.9.2. Financial Performance
- 14.9.3. Product Portfolio
- 14.9.4. Strategic Initiatives
- 14.10. Siemens Healthcare Gmbh
- 14.10.1. Company Overview
- 14.10.2. Financial Performance
- 14.10.3. Product Portfolio
- 14.10.4. Strategic Initiatives